US Broker Ratings

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 71.44% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is capturing investor attention with its innovative approach to organ transplant therapy and a notable potential upside of 71.44%, according to recent analyst ratings. Specializing..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Strong Buy Ratings Signal Potential Upside in Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders. Based in New York..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 9% Upside Potential Amid Diverse Healthcare Offerings

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic medications. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 21.24% Potential Upside in the Healthcare Information Sector

For investors seeking opportunities within the healthcare information services industry, Doximity, Inc. (NYSE: DOCS) presents an intriguing case. With a market capitalization of $3.82 billion, this San Francisco-based company operates..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 17% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the medical instruments and supplies industry, continues to capture the attention of investors with its innovative solutions in orthodontics and digital dentistry...

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Reveal a Potential 91.73% Upside for Investors

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising financial and operational metrics. Based in North Melbourne, Australia, Telix..

Corcept Therapeutics (CORT) Investor Outlook: Navigating Growth in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing investor attention with its promising position in the biotechnology sector. With a market capitalization of $9.37 billion, the company is focused on the..

Masimo Corporation (MASI) Stock Analysis: Exploring Stability in Volatile Markets with a 24.99% ROE

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, is catching the attention of investors with its robust financial performance and strategic product offerings. Headquartered in Irvine,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unpacking a 19% Revenue Growth and a Promising 11.73% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a notable player in the biotechnology sector, presents a compelling investment opportunity, driven by robust revenue growth and a promising upside potential. Headquartered in Dublin,..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 17.96% Upside Potential for Investors

Investors looking for opportunities in the healthcare sector might find IQVIA Holdings, Inc. (NYSE: IQV) an intriguing prospect. With a market capitalization of $31.9 billion, IQVIA is a key player..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Promising Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust revenue growth and potential upside, all while navigating the complexities of..

Regencell Bioscience Holdings (RGC): Navigating Volatility in the Healthcare Sector

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is carving out a niche in the healthcare sector with a focus on neurocognitive disorders,..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Healthcare Powerhouse with a 6.77% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector, continues to capture investor interest with its advanced cardiovascular solutions. With a market capitalization of $52.27 billion, the..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Ups and Downs of a Genomics Leader

Illumina, Inc. (NASDAQ: ILMN) is a heavyweight in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $26.71 billion, the company is a..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Medtronic plc (MDT) Stock Analysis: Exploring a 21% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the healthcare sector specializing in medical devices, continues to draw investor attention with its diverse portfolio and robust financial metrics. Headquartered in Galway,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Capturing 24.84% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry with a market capitalization of $4.28 billion...

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a 48.89% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology sector with a focus on developing therapies for rare and life-threatening diseases. With a current market capitalization of $11.4 billion,..

BrightSpring Health Services, I (BTSG): Strong Buy Ratings Signal Investor Confidence Despite Valuation Challenges

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector with its robust platform offering home and community-based healthcare services. Operating primarily in the United States, BrightSpring provides..

Tenet Healthcare Corporation (THC) Stock Analysis: Unlocking a 28.67% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Tenet Healthcare Corporation (NYSE: THC) presents a compelling case. With a potential upside of 28.67% based on current analyst ratings, Tenet Healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds